The Chin J Cancer Res is published quarterly by Chinese Anti-Cancer Association (CACA) and Springer.

　　 The Chin J Cancer Res, which publishes exclusively in English, is China’s leading journal in cancer sciences. The journal is indexed/abstracted in Science Citation Index Expanded (SCI-E), Journal Citation Reports/Science Edition (JCR), Scientific Search and ISI Web of Science, Chemistry Abstracts, Abstracts Journal (VINITI), Excerpta Medica/EMBASE, Chinainfo (CD & Web), CJFD (CD & Web), CSCD, and CNKI, etc.

　　 The Chin J Cancer Res is an international journal publishing peer-reviewed original articles, reviews, and short communications on basic and clinical studies in oncology. The journal gives a higher priority to review articles that are based mainly on the own work of the authors. The Chin J Cancer Res has an international authorship and a broad scope in multidisciplinary research of cancer etiology and epidemiology, molecular cell biology including cancer cell growth and differentiation, signal transduction, apoptosis, stem cells, etc., cancer immunology, pathology, image diagnosis, surgical & medical oncology, radiation oncology, anti-cancer drugs, as well as Chinese medicine and integrated Chinese and Western medicine in the treatment of malignant disease.

　　The Chin J Cancer Res has established itself as a window for the international academic exchange, and provide a bridge to the world for local medical researchers and professionals.